On June 30, 2026, the National Institutes of Health announced that its All of Us Research Program has become the world’s largest integrated ...
The premise is straightforward — we are awash in biological data. The rapid growth of multiomics datasets (genomics, transcriptomics, proteomics, metabolomics, and radiomics) together with ...
Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...
NEW YORK--(BUSINESS WIRE)--The Food Allergy Fund (FAF) today convened scientists, investors, policymakers, and advocates at its annual Summit in New York City, unveiling advances that mark a pivotal ...
Owkin and Sanofi are expanding their artificial intelligence collaboration through a multi-year agreement to co-develop AI-enabled biopharma agents for drug research and development. Under the new ...
CSIR-IICT scientists have used AI-driven structural bioinformatics to identify a promising repurposed drug candidate against poxviruses, including Mpox and Lumpy Skin Disease Virus.
With the help of artificial intelligence, a coalition of Bay Area institutions identified 18 FDA-approved drugs that could improve the lives of those suffering from amyotrophic lateral sclerosis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results